SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

Needham Maintains Buy on Moderna, Raises Price Target to $58

Needham analyst Alan Carr maintains Moderna (NASDAQ:MRNA) with a Buy and raises the price target from $35 to $58.

Benzinga · 05/07/2020 18:00

Needham analyst Alan Carr maintains Moderna (NASDAQ:MRNA) with a Buy and raises the price target from $35 to $58.